{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:17:09Z","timestamp":1759990629081,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00404-019-05414-3","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T15:07:56Z","timestamp":1576768076000},"page":"289-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2601-3398","authenticated-orcid":false,"given":"Alexander","family":"Hein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael O.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone K.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Fiessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Titz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk C.","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"5414_CR1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12282-017-0789-5","volume":"24","author":"X Yu","year":"2017","unstructured":"Yu X, Zhou S, Wang J et al (2017) Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies. Breast Cancer 24:643\u2013657","journal-title":"Breast Cancer"},{"key":"5414_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2016.05.013","volume":"91","author":"LL Sjogren","year":"2016","unstructured":"Sjogren LL, Morch LS, Lokkegaard E (2016) Hormone replacement therapy and the risk of endometrial cancer: a systematic review. Maturitas 91:25\u201335","journal-title":"Maturitas"},{"key":"5414_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.002","author":"JL Ethier","year":"2017","unstructured":"Ethier JL, Desautels DN, Amir E et al (2017) Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis. Gynecol Oncol. https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.002","journal-title":"Gynecol Oncol"},{"key":"5414_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.06.023","author":"ML Gemignani","year":"2017","unstructured":"Gemignani ML, Hetzel DJ (2017) Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer. Gynecol Oncol. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.023","journal-title":"Gynecol Oncol"},{"key":"5414_CR5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1055\/s-0043-122885","volume":"77","author":"MP Lux","year":"2017","unstructured":"Lux MP, Janni W, Hartkopf AD et al (2017) Update breast cancer 2017 implementation of novel therapies. Geburtshilfe Frauenheilkd 77:1281\u20131290","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5414_CR6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0044-101614","volume":"78","author":"A Schneeweiss","year":"2018","unstructured":"Schneeweiss A, Lux MP, Janni W et al (2018) Update breast cancer 2018 (part 2) advanced breast cancer, quality of life and prevention. Geburtshilfe Frauenheilkd 78:246\u2013259","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5414_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0044-101613","volume":"78","author":"FA Taran","year":"2018","unstructured":"Taran FA, Schneeweiss A, Lux MP et al (2018) Update breast cancer 2018 (part 1) primary breast cancer and biomarkers. Geburtshilfe Frauenheilkd 78:237\u2013245","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5414_CR8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0043-111601","volume":"77","author":"M Untch","year":"2017","unstructured":"Untch M, Huober J, Jackisch C et al (2017) Initial treatment of patients with primary breast cancer: evidence, controversies, consensus: spectrum of opinion of German Specialists at the 15th International St Gallen Breast Cancer Conference (Vienna 2017). Geburtshilfe Frauenheilkd 77:633\u2013644","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5414_CR9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/CEJ.0000000000000111","volume":"24","author":"C Rauh","year":"2015","unstructured":"Rauh C, Gass P, Heusinger K et al (2015) Association of molecular subtypes with breast cancer risk factors: a case-only analysis. Eur J Cancer Prev 24:484\u2013490","journal-title":"Eur J Cancer Prev"},{"key":"5414_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12957-015-0619-1","volume":"13","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhao D, Gong C et al (2015) Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis. World J Surg Oncol 13:208","journal-title":"World J Surg Oncol"},{"key":"5414_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10\u201317","journal-title":"Gynecol Oncol"},{"key":"5414_CR12","first-page":"689","volume":"214","author":"MR Wise","year":"2016","unstructured":"Wise MR, Jordan V, Lagas A et al (2016) Obesity and endometrial hyperplasia and cancer in premenopausal women: a systematic review. Am J Obstet Gynecol 214:689","journal-title":"Am J Obstet Gynecol"},{"key":"5414_CR13","first-page":"107","volume":"208","author":"E Shaw","year":"2016","unstructured":"Shaw E, Farris M, McNeil J et al (2016) Obesity and Endometrial Cancer. Recent results in cancer research. Fortschritte der Krebsforschung Progres dans les recherches sur le Cancer 208:107\u2013136","journal-title":"Fortschritte der Krebsforschung Progres dans les recherches sur le Cancer"},{"key":"5414_CR14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1055-9965.EPI-16-0147","volume":"25","author":"JN Painter","year":"2016","unstructured":"Painter JN, O\u2019Mara TA, Marquart L et al (2016) genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist: hip ratio, is causal for endometrial cancer. Cancer Epidemiol Biomarkers Prev 25:1503\u20131510","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5414_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.120","author":"CG Meireles","year":"2017","unstructured":"Meireles CG, Pereira SA, Valadares LP et al (2017) Effects of metformin on endometrial cancer: systematic review and meta-analysis. Gynecol Oncol. https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.120","journal-title":"Gynecol Oncol"},{"key":"5414_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","volume":"2","author":"HR Harris","year":"2016","unstructured":"Harris HR, Terry KL (2016) Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract 2:14","journal-title":"Fertil Res Pract"},{"key":"5414_CR17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12885-015-1821-9","volume":"15","author":"S Burghaus","year":"2015","unstructured":"Burghaus S, Haberle L, Schrauder MG et al (2015) Endometriosis as a risk factor for ovarian or endometrial cancer results of a hospital-based case-control study. BMC Cancer 15:751","journal-title":"BMC Cancer"},{"key":"5414_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-015-3315-5","volume":"150","author":"J Liu","year":"2015","unstructured":"Liu J, Jiang W, Mao K et al (2015) Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis. Breast Cancer Res Treat 150:439\u2013445","journal-title":"Breast Cancer Res Treat"},{"key":"5414_CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9378(71)90965-3","volume":"111","author":"SB Gusberg","year":"1971","unstructured":"Gusberg SB, Kardon P (1971) Proliferative endometrial response to theca-granulosa cell tumors. Am J Obstet Gynecol 111:633\u2013643","journal-title":"Am J Obstet Gynecol"},{"key":"5414_CR20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","volume":"293","author":"HK Ziel","year":"1975","unstructured":"Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167\u20131170","journal-title":"N Engl J Med"},{"key":"5414_CR21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","volume":"293","author":"DC Smith","year":"1975","unstructured":"Smith DC, Prentice R, Thompson DJ et al (1975) Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293:1164\u20131167","journal-title":"N Engl J Med"},{"key":"5414_CR22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","volume":"365","author":"V Beral","year":"2005","unstructured":"Beral V, Bull D, Reeves G et al (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365:1543\u20131551","journal-title":"Lancet"},{"key":"5414_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002229.pub4:CD002229","author":"HM Boardman","year":"2015","unstructured":"Boardman HM, Hartley L, Eisinga A et al (2015) Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002229.pub4:CD002229","journal-title":"Cochrane Database Syst Rev"},{"key":"5414_CR24","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/cam4.1445","volume":"7","author":"JN Painter","year":"2018","unstructured":"Painter JN, O\u2019Mara TA, Morris AP et al (2018) Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Med 7:1978\u20131987","journal-title":"Cancer Med"},{"key":"5414_CR25","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41467-018-05427-7","volume":"9","author":"TA O\u2019Mara","year":"2018","unstructured":"O\u2019Mara TA, Glubb DM, Amant F et al (2018) Identification of nine new susceptibility loci for endometrial cancer. Nat Commun 9:3166","journal-title":"Nat Commun"},{"key":"5414_CR26","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/hmg\/ddu552","volume":"24","author":"JN Painter","year":"2015","unstructured":"Painter JN, O\u2019Mara TA, Batra J et al (2015) Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum Mol Genet 24:1478\u20131492","journal-title":"Hum Mol Genet"},{"key":"5414_CR27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/1055-9965.EPI-12-0903","volume":"22","author":"RJ Delahanty","year":"2013","unstructured":"Delahanty RJ, Xiang YB, Spurdle A et al (2013) Polymorphisms in inflammation pathway genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 22:216\u2013223","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5414_CR28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1158\/1055-9965.EPI-11-1160","volume":"21","author":"J Long","year":"2012","unstructured":"Long J, Zheng W, Xiang YB et al (2012) Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiol Biomarkers Prev 21:980\u2013987","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5414_CR29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.812","volume":"43","author":"AB Spurdle","year":"2011","unstructured":"Spurdle AB, Thompson DJ, Ahmed S et al (2011) Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 43:451\u2013454","journal-title":"Nat Genet"},{"key":"5414_CR30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ng.3562","volume":"48","author":"TH Cheng","year":"2016","unstructured":"Cheng TH, Thompson DJ, O\u2019Mara TA et al (2016) Five endometrial cancer risk loci identified through genome-wide association analysis. Nat Genet 48:667\u2013674","journal-title":"Nat Genet"},{"key":"5414_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/ERC-15-0386","volume":"23","author":"DJ Thompson","year":"2016","unstructured":"Thompson DJ, O\u2019Mara TA, Glubb DM et al (2016) CYP19A1 fine-mapping and mendelian randomization: estradiol is causal for endometrial cancer. Endocr Relat Cancer 23:77\u201391","journal-title":"Endocr Relat Cancer"},{"key":"5414_CR32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/ERC-15-0319","volume":"22","author":"TA O\u2019Mara","year":"2015","unstructured":"O\u2019Mara TA, Glubb DM, Painter JN et al (2015) Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocr Relat Cancer 22:851\u2013861","journal-title":"Endocr Relat Cancer"},{"key":"5414_CR33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrendo.2016.164","volume":"13","author":"RA Lobo","year":"2017","unstructured":"Lobo RA (2017) Hormone-replacement therapy: current thinking. Nat Rev Endocrinol 13:220\u2013231","journal-title":"Nat Rev Endocrinol"},{"key":"5414_CR34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"5414_CR35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1055\/s-2007-965815","volume":"67","author":"A Katalinic","year":"2007","unstructured":"Katalinic A, Stegmaier C, Rawal R et al (2007) Less hormone replacement therapy, less breast cancer in Germany? Geburtshilfe Frauenheilkd 67:1217\u20131221","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5414_CR36","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-54630-7","volume-title":"Arzneiverordnungs-report 2017","author":"U Schwabe","year":"2017","unstructured":"Schwabe U, Paffrath D, Ludwig WD (2017) Arzneiverordnungs-report 2017. Springer, Berlin"},{"key":"5414_CR37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2013.06.011","volume":"142","author":"HN Hodis","year":"2014","unstructured":"Hodis HN, Mack WJ (2014) Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis. J Steroid Biochem Mol Biol 142:68\u201375","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5414_CR38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","volume":"310","author":"JE Manson","year":"2013","unstructured":"Manson JE, Chlebowski RT, Stefanick ML et al (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials. JAMA 310:1353\u20131368","journal-title":"JAMA"},{"key":"5414_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv350","author":"RT Chlebowski","year":"2016","unstructured":"Chlebowski RT, Anderson GL, Sarto GE et al (2016) Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women\u2019s Health Initiative Randomized Trial. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv350","journal-title":"J Natl Cancer Inst"},{"key":"5414_CR40","first-page":"4","volume":"66","author":"MW Beckmann","year":"2006","unstructured":"Beckmann MW, Gitsch G, Emons G et al (2006) The newly established subspecialty gynecological oncology a national and an international chance? Geburtshilfe Frauenheilkd 66:4","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5414_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/WHE.14.13","volume":"10","author":"PS Binder","year":"2014","unstructured":"Binder PS, Mutch DG (2014) Update on prognostic markers for endometrial cancer. Womens Health (London) 10:277\u2013288","journal-title":"Womens Health (London)"},{"key":"5414_CR42","first-page":"28","volume":"133","author":"EM Ko","year":"2014","unstructured":"Ko EM, Walter P, Clark L et al (2014) The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol 133:28\u201332","journal-title":"Gynecol Oncol"},{"key":"5414_CR43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2015.10.020","volume":"140","author":"AA Secord","year":"2016","unstructured":"Secord AA, Hasselblad V, Von Gruenigen VE et al (2016) Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 140:184\u2013190","journal-title":"Gynecol Oncol"},{"key":"5414_CR44","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/bcr2467","volume":"12","author":"SF Marshall","year":"2010","unstructured":"Marshall SF, Clarke CA, Deapen D et al (2010) Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort. Breast Cancer Res 12:R4","journal-title":"Breast Cancer Res"},{"key":"5414_CR45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0035-1546149","volume":"75","author":"C Rauh","year":"2015","unstructured":"Rauh C, Schuetz F, Rack B et al (2015) Hormone therapy and its effect on the prognosis in breast cancer patients. Geburtshilfe Frauenheilkd 75:588\u2013596","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"342","key":"5414_CR46","first-page":"e341","volume":"196","author":"F Schuetz","year":"2007","unstructured":"Schuetz F, Diel IJ, Pueschel M et al (2007) Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Am J Obstet Gynecol 196(342):e341\u2013349","journal-title":"Am J Obstet Gynecol"},{"key":"5414_CR47","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","volume":"385","author":"V Beral","year":"2015","unstructured":"Collaborative Group on Epidemiological Studies of Ovarian C, Beral V, Gaitskell K et al (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835\u20131842","journal-title":"Lancet"},{"key":"5414_CR48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.23956","volume":"115","author":"CL Pearce","year":"2009","unstructured":"Pearce CL, Chung K, Pike MC et al (2009) Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 115:531\u2013539","journal-title":"Cancer"},{"key":"5414_CR49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/CEJ.0b013e328355ec22","volume":"22","author":"A Hein","year":"2013","unstructured":"Hein A, Thiel FC, Bayer CM et al (2013) Hormone replacement therapy and prognosis in ovarian cancer patients. Eur J Cancer Prev 22:52\u201358","journal-title":"Eur J Cancer Prev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05414-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:14:49Z","timestamp":1608250489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5414"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05414-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"1 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There were no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}